Metabolomics During Testosterone Therapy

Clinical Trial ID NCT01963390

Rank	Title	Journal	Year	PubWeight™‹?›
1	Metabolite profiles and the risk of developing diabetes.	Nat Med	2011	12.22
2	Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.	J Clin Invest	2011	3.23
3	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	2.51
4	Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.	Eur J Endocrinol	2006	2.46
5	Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.	J Androl	2009	1.47